ActHIB with DPT Interactions
There are 297 drugs known to interact with ActHIB with DPT (diphtheria toxoid / haemophilus b conjugate (prp-t) vaccine / pertussis, acellular / tetanus toxoid), along with 5 disease interactions. Of the total drug interactions, 1 is major, 293 are moderate, and 3 are minor.
- View all 297 medications that may interact with ActHIB with DPT
- View ActHIB with DPT disease interactions (5)
Most frequently checked interactions
View interaction reports for ActHIB with DPT (diphtheria toxoid / haemophilus b conjugate (prp-t) vaccine / pertussis, acellular / tetanus toxoid) and the medicines listed below.
- Aller-Tec (cetirizine)
- Aveidaoxia (ivermectin / metronidazole / niacinamide topical)
- azelastine nasal
- biotin
- Breo Ellipta (fluticasone / vilanterol)
- Caltrate 600+D (calcium / vitamin d)
- ciclopirox topical
- Coenzyme Q10 (ubiquinone)
- cranberry
- diclofenac
- Eliquis (apixaban)
- EpiPen (epinephrine)
- Klor-Con 8 (potassium chloride)
- losartan
- magnesium oxide
- MiraLAX (polyethylene glycol 3350)
- Ozempic (semaglutide)
- Pfizer-BioNTech COVID-19 Vaccine (COVID-19 mRNA (Pfizer) vaccine)
- Premarin Vaginal (conjugated estrogens topical)
- Refresh Plus (ocular lubricant ophthalmic)
- Repatha (evolocumab)
- rsv vaccine pref3, recombinant
- sotalol
ActHIB with DPT disease interactions
There are 5 disease interactions with ActHIB with DPT (diphtheria toxoid / haemophilus b conjugate (prp-t) vaccine / pertussis, acellular / tetanus toxoid) which include:
Report options
More about ActHIB with DPT (diphtheria toxoid / haemophilus b conjugate (prp-t) vaccine / pertussis, acellular / tetanus toxoid)
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.